Switch to: References

Add citations

You must login to add citations.
  1. Multi-Stakeholder Initiatives on Sustainability: A Cross-Disciplinary Review and Research Agenda for Business Ethics.Frank G. A. de Bakker, Andreas Rasche & Stefano Ponte - 2019 - Business Ethics Quarterly 29 (3):343-383.
    ABSTRACT:Although the literature on multi-stakeholder initiatives for sustainability has grown in recent years, it is scattered across several academic fields, making it hard to ascertain how individual disciplines, such as business ethics, can further contribute to the debate. Based on an extensive review of the literature on certification and principle-based MSIs for sustainability, we show that the scholarly debate rests on three broad themes : theinputinto creating and governing MSIs; theinstitutionalizationof MSIs; and theimpactthat relevant initiatives create. While our discussion reveals (...)
    Download  
     
    Export citation  
     
    Bookmark   35 citations  
  • What Have Firms Been Doing? Exploring What KLD Data Report About Firms’ Corporate Social Performance in the Period 2000-2010.Michael A. Quinn & Elise Perrault - 2018 - Business and Society 57 (5):890-928.
    With the blossoming of research on corporate social performance, the data produced by Kinder, Lydenberg, Domini have become the standard to measure firms’ social and stakeholder actions. However, to date, only a few studies have focused on examining the data directly, and have done so largely in terms of validating the concepts and methods in the data set’s construction. The present study seeks to complement these efforts by contributing knowledge about what the KLD data report on firms’ actions toward primary (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX.Markus Scholz, N. Craig Smith, Maria Riegler & Anna Burton - forthcoming - Business and Society.
    Pharmaceutical companies developed Covid-19 vaccines in record time. However, it soon became apparent that global access to the vaccines was inequitable. Through a qualitative inquiry as the pandemic unfolded (to mid-2021), we provide an in-depth analysis of why companies engaged with the Covid-19 Vaccines Global Access Facility (COVAX), identifying the internal (to the company) and external factors that facilitated or impeded engagement. While all producers of the World Health Organization (WHO)-approved vaccines engaged with COVAX, our analysis highlights the differential levels (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Civil Society Roles in CSR Legislation.Guillaume Delalieux, Arno Kourula & Eric Pezet - 2023 - Journal of Business Ethics 190 (2):347-370.
    While Corporate Social Responsibility (CSR) is often seen to involve voluntary and deliberative approaches such as certification, governments have recently stepped into the picture through national legislation. France’s Law on Duty of Vigilance adopted in 2017 is a landmark case of such legislation. Years of voluntary CSR certification schemes led by Civil Society were replaced by a new philosophy of fighting for mandatory CSR controlled by a judge. We depict the change of mindset and the related change of roles inside (...)
    Download  
     
    Export citation  
     
    Bookmark